Aviron Report issue

For profit Phase 3
Founded: Mountain View CA United States (1992)
Status: Acquired by MedImmune (2001) → now AstraZeneca (2007)

Organization Overview

First Clinical Trial
2000
NCT00001127
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Aviron LLC

Active Ingredients

Drugs in Phase 3 Trials (1)

live attenuated influenza virus vaccine (Flumist) (1 trial)

Drugs in Other Trials (1)

aprotinin (trasylol) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Influenza, Human (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2